{"name":"Birte Glenthoj","slug":"birte-glenthoj","ticker":"","exchange":"","domain":"","description":"Birte Glenthoj is a pharmaceutical company with a focus on developing treatments for neurological disorders. The company has one drug in its pipeline, which is currently discontinued. Limited information is available about the company's financials and operations.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5QZFB2ck51aTR3TndCc2ZQWEo0ZGk1endQVmRVSVNuR3pxU1M2Qk9CY1NsYWlyVlV5UXJ5MC1DZ0dJX0Qxcy1HLTJpSW5XRVkyeE0zbXctc01YX0hsbTFXaW9TRnUxdVVwWFNB?oc=5","date":"2024-08-12","type":"pipeline","source":"Wiley Online Library","summary":"Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naïve patients with first-episode psychosis - Wiley Online Library","headline":"Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naïve pati","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}